
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression
Lijun Wu, Ke Li, Wei Lin, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 3-4, pp. 341-357
Open Access | Times Cited: 13
Lijun Wu, Ke Li, Wei Lin, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 3-4, pp. 341-357
Open Access | Times Cited: 13
Showing 13 citing articles:
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
Marina Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone
Cells (2022) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 33
Marina Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone
Cells (2022) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 33
Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies
Zeinab Chaharlashkar, Yousof Saeedi Honar, Meghdad Abdollahpour‐Alitappeh, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312754-e0312754
Open Access
Zeinab Chaharlashkar, Yousof Saeedi Honar, Meghdad Abdollahpour‐Alitappeh, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312754-e0312754
Open Access
The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review
Hoda Fazaeli, Azar Sheikholeslami, Fatemeh Ghasemian, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 7, pp. 606-629
Closed Access | Times Cited: 13
Hoda Fazaeli, Azar Sheikholeslami, Fatemeh Ghasemian, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 7, pp. 606-629
Closed Access | Times Cited: 13
Long non-coding RNAs and melanoma: From diagnosis to therapy
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Golnesa Kazemioula, et al.
Pathology - Research and Practice (2022) Vol. 241, pp. 154232-154232
Closed Access | Times Cited: 13
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Golnesa Kazemioula, et al.
Pathology - Research and Practice (2022) Vol. 241, pp. 154232-154232
Closed Access | Times Cited: 13
Crucial Roles of miR-625 in Human Cancer
Menggang Zhang, Fei Xiong, Shuijun Zhang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Menggang Zhang, Fei Xiong, Shuijun Zhang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.
Ennio Nano, Francesco Reggiani, Adriana Amaro, et al.
(2024)
Open Access | Times Cited: 1
Ennio Nano, Francesco Reggiani, Adriana Amaro, et al.
(2024)
Open Access | Times Cited: 1
LINC01291 promotes hepatocellular carcinoma development by targeting the miR‐186‐5p/OXSR1 axis
Jian Chu, Guang-Yong Geng, Xiaoming Ai, et al.
The Journal of Gene Medicine (2021) Vol. 24, Iss. 2
Closed Access | Times Cited: 8
Jian Chu, Guang-Yong Geng, Xiaoming Ai, et al.
The Journal of Gene Medicine (2021) Vol. 24, Iss. 2
Closed Access | Times Cited: 8
APOBEC3B expression is promoted by lincNMR collaborating with TGF-β–Smad pathway
Kosuke Ota, Satoshi Sakai, Tatsuya Ohhata, et al.
Carcinogenesis (2022) Vol. 44, Iss. 1, pp. 1-14
Closed Access | Times Cited: 3
Kosuke Ota, Satoshi Sakai, Tatsuya Ohhata, et al.
Carcinogenesis (2022) Vol. 44, Iss. 1, pp. 1-14
Closed Access | Times Cited: 3
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis
Anas Mohammed, Ahmad Khan, Xiaobo Zhang
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Anas Mohammed, Ahmad Khan, Xiaobo Zhang
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Ennio Nano, Francesco Reggiani, Adriana Amaro, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 46-46
Open Access
Ennio Nano, Francesco Reggiani, Adriana Amaro, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 46-46
Open Access
Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies
Yuai Xiao, Yu Xia, Yuchong Wang, et al.
Genes & Diseases (2021) Vol. 10, Iss. 1, pp. 113-125
Open Access | Times Cited: 3
Yuai Xiao, Yu Xia, Yuchong Wang, et al.
Genes & Diseases (2021) Vol. 10, Iss. 1, pp. 113-125
Open Access | Times Cited: 3
Noncoding RNAs: emerging players in skin cancers pathogenesis.
Lin Li, Suliman Khan, Song Li, et al.
PubMed (2021) Vol. 11, Iss. 11, pp. 5591-5608
Closed Access | Times Cited: 2
Lin Li, Suliman Khan, Song Li, et al.
PubMed (2021) Vol. 11, Iss. 11, pp. 5591-5608
Closed Access | Times Cited: 2
Exosomal Non-coding RNAs: A New Approach to Melanoma Diagnosis and Therapeutic Strategy
Jie Liu, Xiao Hu, Wenqiang Xin, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6084-6109
Closed Access
Jie Liu, Xiao Hu, Wenqiang Xin, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6084-6109
Closed Access